Compassionate use of simeprevir in Europe for liver transplant recipients with recurrent Hepatitis C.

Trial Profile

Compassionate use of simeprevir in Europe for liver transplant recipients with recurrent Hepatitis C.

Completed
Phase of Trial: Phase IV

Latest Information Update: 15 Dec 2015

At a glance

  • Drugs Simeprevir (Primary) ; Daclatasvir; Sofosbuvir
  • Indications Hepatitis C
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    No Data Available
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top